Literature DB >> 29584516

Effect of Intermittent Hypoxia Training for Dizziness: A Randomized Controlled Trial.

Xiao Bao, Jie-Wen Tan, Ying Long, Howe Liu, Hui-Yu Liu.   

Abstract

OBJECTIVE: To study the effect of intermittent hypoxia training (IHT) for dizziness.
DESIGN: A single-blind, randomized controlled trial. All participants were recruited from a rehabilitation department in an acute university-affiliated hospital. INTERVENTION: Participants with dizziness were randomly assigned to 2 groups (IHT group and control group). The Dizziness Handicap Inventory, Activities-specific Balance Confidence Scale, and Vertigo Visual Analog Scale were conducted at baseline, end of the fourth week.
RESULTS: Among 52 subjects, there were18 males and 34 females, ages 35 to 62 years old (mean [SD] = 46.9 [7.93]). Time length since onset ranged from 12 to 34 months (20.2 [7.15] mo). Dizziness Handicap Inventory, Activities-specific Balance Confidence Scale, Vertigo Visual Analog Scale scores, and attack frequencies of dizziness were improved after IHT intervention in the end of the fourth week. There were significant differences between the IHT group and the control group in the Dizziness Handicap Inventory, Activities-specific Balance Confidence Scale, Vertigo Visual Analog Scale scores, and attack frequencies of dizziness at the end of the fourth week (P < .05). No adverse events occurred during the study.
CONCLUSION: IHT could improve dizziness after intervention at the end of the fourth week. IHT could be the effective method for treating dizziness.

Entities:  

Keywords:  dizziness; intermittent hypoxia training; vascular function

Year:  2019        PMID: 29584516     DOI: 10.1123/jsr.2017-0341

Source DB:  PubMed          Journal:  J Sport Rehabil        ISSN: 1056-6716            Impact factor:   1.931


  1 in total

1.  Effects of Intermittent Hypoxia in Training Regimes and in Obstructive Sleep Apnea on Aging Biomarkers and Age-Related Diseases: A Systematic Review.

Authors:  Belay Tessema; Ulrich Sack; Brigitte König; Zoya Serebrovska; Egor Egorov
Journal:  Front Aging Neurosci       Date:  2022-05-23       Impact factor: 5.702

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.